SUM149 cells were isolated from an inflammatory breast cancer patient whose tumor was defined as “triple negative” but which nevertheless in our hands expressed detectable basal levels of ERBB1, ERBB2, ERBB3, and ERBB4 by immuno-fluorescence of cells fixed in situ (Figure 5A). This evidence concerns the gene EGFR and breast carcinoma.